ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics Inc (LCTX)

0.5703
-0.0285
( -4.76% )
Updated: 10:54:25

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 1.92M2.39M3.23M1.25M2.09M1.44M1.41M3.78M
Operating Income -6.64M-6.64M-5.02M-6.71M-6.36M-6.66M-5.87M-3.84M
Pre Tax Income -6.36M-6.21M-5.2M-7.16M-4.71M-6.56M-5.77M-3M
Net Income -6.35M-4.37M-5.23M-7.11M-4.78M-6.54M-5.76M-3.03M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -6.24M-6.66M-5.44M-7.53M-5.11M-6.66M-5.85M-3.84M
EBITDA -6.47M-6.47M-4.85M-6.53M-6.19M-6.49M-5.73M-3.7M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 5.92M3.46M4.99M3.52M1.83M4.34M14.7M8.95M
Operating Income -29.28M-94.7M-129.41M-38.88M-26.45M-49.21M-22.52M-24.73M
Pre Tax Income 18.62M-23.29M-47.13M-19.23M-21.92M-43.27M-25.81M-23.28M
Net Income 33.57M-19.98M-45.99M-11.71M-20.65M-43.02M-26.27M-21.49M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0.326-0.157-0.362-0.078-0.135-0.254-0.154-0.123
EBIT 19.37M-22.6M-51.06M-36.34M-23.57M-47.73M-24.67M-24.74M
EBITDA -24.52M-91.4M-126.14M-35.88M-24.34M-48.32M-21.79M-24.04M

Your Recent History

Delayed Upgrade Clock